pharma · Peripheral Artery Disease · Muscle-Invasive Bladder Carcinoma
Blackmores Institute
Blackmores Limited
Blackmores Institute clinical programs — 17 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 20 Jubilee Ave, Warriewood, New South Wales 2102, AU
- Founded
- 2012
- Employees
- 27
- Programs
- 17
- Drugs
- 24
- Patents
- 38
Blackmores Institute projects
17 ClinicalTrials.gov programs sponsored by Blackmores Institute.
Blackmores Institute has 17 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Active Surveillance
Blackmores Limited
Muscle-Invasive Bladder Carcinoma
1 trial -
Placebo
Blackmores Limited
Parkinsons Disease (PD)
1 trial -
GARM-Autism Adults
Blackmores Limited
Autism Spectrum Disorder
1 trial -
PTH
Blackmores Limited
Osteoporosis
1 trial -
silevertinib (BDTX-1535) monotherapy
Blackmores Limited
Non-Small Cell Lung Cancer
1 trial -
silevertinib in combination with temozolomide
Blackmores Limited
Glioblastoma (GBM)
1 trial -
Azathioprine 50Mg Tab
Blackmores Limited
Therapeutic Equivalency
1 trial -
BDTX-189
Blackmores Limited
Solid Tumor
1 trial -
Levodopa
Blackmores Limited
Parkinson's Disease
1 trial -
Liberase Enzyme (Roche)
Blackmores Limited
Pulmonary Alveolar Proteinosis
1 trial -
Normal Saline (NS) .9% 10 mL Injection
Blackmores Limited
Ovarian Failure
1 trial -
YF476
Blackmores Limited
Hypergastrinaemia
2 trials -
Chocolate PTA Balloon
Blackmores Limited
Atherosclerosis
1 trial -
Liposomal bupivacaine
Blackmores Limited
Liposomal Bupivacaine
1 trial -
DGB-01 Supplementation
Blackmores Limited
Fatigue
1 trial -
Percutaneous Transluminal Angioplasty (PTA)
Blackmores Limited
Peripheral Artery Disease
1 trial -
ZKSJ0132
Blackmores Limited
Peripheral Artery Disease
1 trial
Frequently asked questions
How many clinical projects does Blackmores Institute have?
17 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.